Extracellular vesicles as new-age vaccine carriers: a focused account on viral diseases
By
Roopali Rajput
Madhu Khanna
Radhika
Jitender Sharma
Hardeep Kaur
June 19, 2026
Clinical Scorecard: Extracellular Vesicles: Innovative Vaccine Delivery Systems for Viral Infections
At a Glance
Category Detail
Condition Viral Infections Key Mechanisms Extracellular vesicles (EVs) serve as carriers of immunogens, facilitating antigen presentation and immune response. Target Population Individuals at risk of viral infections. Care Setting Biomedical research and vaccine development.
Key Highlights
EVs provide safety and effective antigen presentation for vaccines. Research on EVs is expanding, focusing on their role in vaccine delivery. EVs have shown potential in eliciting robust immune responses against various viruses. Engineering strategies for EVs are being explored to enhance vaccine efficacy. EVs can cross biological barriers, such as the blood-brain barrier. Guideline-Based Recommendations
Diagnosis
Utilize EVs for targeted delivery of viral antigens. Management
Explore engineering strategies to optimize EVs for vaccine applications. Monitoring & Follow-up
Assess immune responses elicited by EV-based vaccines in clinical studies. Risks
Consider potential immunopathogenesis associated with specific viral antigens. Patient & Prescribing Data
Patients requiring vaccination against viral infections.
EVs can enhance the delivery and efficacy of vaccines targeting various viral pathogens.
Clinical Best Practices
Engage in ongoing research to refine EV engineering for vaccine delivery. Monitor the safety and efficacy of EV-based vaccines in clinical trials. Collaborate across disciplines to advance the application of EVs in vaccine development. Related Resources & Content
